Novartis hemoglobinuria trial meets two primary endpoints
admin Novartis AG NOVN, +0.47% NVS, +2.05% said Monday that a study on a drug to…
Read Morenew products
Apple, Spotify should ‘stop working’ with Kanye West, says Ari Emanuel
Entertainment industry super-agent Ari Emanuel is asking businesses to stop working with Kanye West after…
Read MoreWaymo plans to launch driverless taxi service in Los Angeles
Waymo is targeting Los Angeles as its next location to launch a driverless taxi service.…
Read MoreUber to allow marketers to target riders with ads based on destination
Ride-hailing company Uber Technologies Inc. UBER, -1.21% wants to help marketers target consumers with ads…
Read MoreApple introduces new iPad and iPad Pro with speed enhancements
Apple Inc. quietly announced upgrades to two of its iPhone models Tuesday, through announcements lacking…
Read MoreNFT trading volume is at an all time low, but this CEO is still betting big on the technology
The buzz and hype have faded, but RECUR, a company that helps brands create and…
Read MoreAds are coming to Netflix in November with plan costing $6.99 a month
Netflix Inc. announced Thursday that its new ad-supported tier will debut Nov. 3 in the…
Read MoreFresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot
A flurry of announcements Thursday on COVID vaccines and boosters offered further evidence and support…
Read MoreFresh data supports updated boosters targeting omicron subvariants, raising hopes more Americans will get the shot
A flurry of announcements Thursday on COVID vaccines and boosters offered further evidence and support…
Read MoreGSK respiratory syncytial virus vaccine Phase 3 trial meets primary endpoint
GSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine…
Read More